Skip to content

Genetic Determinants and Clinical Consequences of Early-onset Severe Obesity

Genetic Determinants and Clinical Consequences of Early-onset Severe Obesity

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02645422
Acronym
PeLi
Enrollment
400
Registered
2016-01-01
Start date
2015-12-31
Completion date
2023-12-31
Last updated
2023-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Obesity

Brief summary

The aim of the present study is to identify new obesity-related genetic defects and determine their association with clinical manifestations in families with childhood-onset severe obesity. The investigators hypothesize that by exploring children with severe early-onset obesity they can find new obesity-related genetic defects and by exploring obesity-associated clinical manifestations the investigators can elucidate the outcomes of severe childhood obesity.

Detailed description

Obesity is a complex disorder with many contributing genetic and environmental factors. The genetic causes and mechanisms for severe childhood obesity are still incompletely understood. It is acknowledged that obesity in some individuals could be a consequence of rare genetic variants with strong effect - these rare variants might be population specific. The aims of this study are to determine * inheritance patterns of early-onset obesity * new obesity-related genetic variants and disease-causing gene mutations * the association between obesity-related genetic defects and clinical manifestations * the association between obesity-related genetic defects and psychiatric symptoms in patients with early-onset obesity and their first-degree relatives Significant advancements in genetic methodology provide new tools to explore genetic defects underlying obesity. Family-based approach provides several advantages compared to cohort studies to investigate genetic determinants of complex diseases.The unique genetic composition of the Finnish population enables identification of novel genetic entities. Discovery of genetic defects associated with severe childhood-onset obesity will increase the investigators understanding of the pathogenesis of obesity and allows early detection, by genetic testing, of those at increased risk and optimal targeting of preventive measures.

Interventions

None listed

Sponsors

Folkhälsan Researech Center
CollaboratorOTHER
Karolinska Institutet
CollaboratorOTHER
Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* children and adolescents age 10-18 years * height-adjusted weight \>60 % before the age of 7 years. * Finnish descent

Exclusion criteria

* patients with a known endocrine or genetic disorder underlying obesity (e.g. Prader-Willi syndrome, hypercortisolism, hypothyroidism)

Design outcomes

Primary

MeasureTime frame
Number of patients with gene mutations or genetic variants in children with early-onset severe obesityBaseline, first day of enrollment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026